Home » Newsletters » BioWorld Science

BioWorld Science

May 23, 2002

View Archived Issues

rSP-C surfactant treatment tends to reduce mortality in patients with ARDS

Merck and Tularik present novel HIV integrase inhibitors

Novel MMP inhibitors identified by Pfizer research group

Gastric antisecretory agents patented by Byk Gulden

Novel retinoids and their use in pulmonary emphysema, cancer and skin disorders

NMDA channel blockers identified by U.S. university researchers

Prednisone prolongs survival in multiple myeloma patients

Novel protein kinase inhibitors discovered at Pfizer

Genta initiates gallium nitrate program for NHL

Antibacterial and antiinflammatory agents claimed by SUNY

Antisense compound identified with potential in cardiovascular disease

HGS and CAT to develop TRAIL-R2 MAb

ISS-1018 enters phase I in asthma

Amantadine as an effective and safe alternative to interferon in HCV infection

Selective CCKB/gastrin receptor antagonist evaluated in rat model of GERD

Rabeprazole effective for heartburn and symptoms of NERD

Novel antidiabetic lowers only elevated blood glucose levels and stimulates insulin release

Antigen-induced bronchospasm ameliorated by treatment with SOD mimetic

New data on treprostinil discussed at ATS 2002

Blockade of IL-5 with MAb selectively reduces eosinophils in bone marrow and peripheral blood

Low-dose formulation of Retin-A Micro approved by FDA

NicOx and Axcan sign codevelopment and license agreement for NCX-1000 in chronic liver diseases

Panacea receives SBIR grant for anti-HAAH cancer drugs

FDA advisory committee supports efficacy of Prevnar in otitis media

Pharmagene and Argenta Discovery collaborate on migraine and IBS programs

Restoragen restructures and refocuses

Phase I trial begins for first candidate to emerge from Vernalis/Roche obesity collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...